Kernal Biologics is a seed startup. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
Kernal Biologics is a pre-clinical stage mRNA therapeutics company developing novel mRNA-based therapies for difficult-to-treat cancers. Kernal Biologics is focused on leveraging its proprietary mRNA 2.0 platform to design and develop innovative cancer therapeutics that can overcome the limitations of existing cancer treatments.
Stage
seed
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky